Extract of Litsea japonica ameliorates blood-retinal barrier breakdown in db/db mice

Endocrine. 2014 Aug;46(3):462-9. doi: 10.1007/s12020-013-0085-x. Epub 2013 Nov 28.

Abstract

Loss of blood-retinal barrier (BRB) properties is an important feature in the pathology of diabetic retinopathy. Endothelium integrity is important for the normal vascular function. Litsea japonica (Thunb.) Jussieu is a Korean native plant that is consumed as a vegetable food. In this study, we evaluated the ability of an ethanol extract of L. japonica to prevent retinal vascular leakages in db/db mice, which is an animal model of type II diabetes. L. japonica extracts (LJE, 100 and 250 mg/kg) were administered once a day, orally, for 12 weeks. Vehicle-treated db/db mice exhibited hyperglycemia and retinal vascular leakage. LJE treatment blocked diabetes-induced BRB breakdown and decreased retinal VEGF expression in db/db mice. LJE also inhibited the degradation of occludin, which is an important tight junction protein. These findings support the potential therapeutic usefulness of L. japonica for retinal vascular permeability diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood-Retinal Barrier / drug effects*
  • Blood-Retinal Barrier / metabolism
  • Blood-Retinal Barrier / pathology
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / pathology
  • Diabetic Retinopathy / drug therapy*
  • Diabetic Retinopathy / metabolism
  • Diabetic Retinopathy / pathology
  • Litsea*
  • Mice
  • Occludin / metabolism
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Occludin
  • Plant Extracts
  • Vascular Endothelial Growth Factor A